-
Ziprasidone Inhibits Pancreatic Cancer via GOT1-Redox Axis D
2026-05-08
This study demonstrates that ziprasidone is a novel non-competitive inhibitor of GOT1, suppressing pancreatic ductal adenocarcinoma (PDAC) proliferation by disrupting glutamine metabolism and redox homeostasis. These findings highlight GOT1 as a promising therapeutic target in PDAC and reinforce the centrality of metabolic redox regulation in tumor biology.
-
Angiotensin III (human, mouse): Receptor Selectivity and Cro
2026-05-07
Explore the nuanced role of Angiotensin III (human, mouse) in cardiovascular and viral research. This article reveals advanced insights into receptor selectivity, assay protocols, and cross-domain implications, offering researchers a unique perspective beyond standard workflow guides.
-
Rotenone: Mitochondrial Complex I Inhibitor in Disease Model
2026-05-07
Rotenone's precision as a mitochondrial Complex I inhibitor enables robust modeling of mitochondrial dysfunction, apoptosis pathways, and neurodegenerative diseases such as Parkinson's. This article delivers actionable protocols, workflow optimization tips, and translational insight, leveraging recent advances to maximize experimental rigor.
-
Scenario-Driven Solutions with 12-O-tetradecanoyl phorbol-13
2026-05-06
This article guides biomedical scientists through real-life challenges in cell signaling, viability, and cytotoxicity assays, demonstrating how 12-O-tetradecanoyl phorbol-13-acetate (TPA, SKU N2060) delivers reproducible ERK/MAPK pathway activation. By leveraging peer-reviewed evidence and scenario-based solutions, researchers gain practical insights into optimizing experimental workflows using APExBIO's TPA.
-
Technical Guide: HyperScribe™ T7 High Yield Cy3 RNA Labeling
2026-05-06
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus addresses the need for reproducible, high-yield fluorescent RNA probe synthesis in research workflows. It is most appropriate for applications such as in situ hybridization and Northern blotting, but is not validated for diagnostic or clinical use.
-
CHIR-99021 (CT99021): Driving Stem Cell Pluripotency and Dif
2026-05-05
CHIR-99021 (CT99021) unlocks robust control of Wnt/β-catenin and related pathways, enabling precise pluripotency maintenance and directed differentiation workflows. Its unparalleled selectivity and reproducibility empower organoid engineering, advanced disease modeling, and regenerative protocol innovation.
-
A-1331852: Advanced BCL-XL Inhibitor Workflows in Cancer Res
2026-05-05
A-1331852 from APExBIO enables precise, selective inhibition of BCL-XL, offering unparalleled potency in apoptosis assays and cancer research models. This guide delivers actionable protocol enhancements, comparative insights, and troubleshooting strategies to empower bench scientists targeting BCL-2 family proteins.
-
Pregnenolone Carbonitrile: Gut-Liver Axis and Hepatic Protec
2026-05-04
Explore how Pregnenolone Carbonitrile modulates the gut-liver axis and advances hepatic detoxification research. This in-depth guide unveils new insights into PXR agonist mechanisms, antifibrotic action, and the pivotal role of microbiota in liver injury models.
-
Annexin V-FITC/7-AAD Apoptosis Kit: Technical Workflow Guide
2026-05-04
The Annexin V-FITC/7-AAD Apoptosis Kit enables rapid and reliable discrimination of apoptotic and necrotic cells, supporting established cell viability and cytotoxicity assays. It is best suited for flow cytometry or fluorescence microscopy workflows where clear differentiation of cell death stages is required, but is not intended for mechanistic pathway elucidation or detection of atypical cell death forms.
-
Large-Scale Microraft Arrays Advance Human Gastruloid Screen
2026-05-03
Jan et al. (2025) present an automated microraft array platform enabling high-throughput screening and sorting of human gastruloids at single-structure resolution. This innovation enhances the study of chromosomal abnormalities and spatial gene expression in early development, with broad implications for developmental biology and translational research.
-
A-1210477: MCL-1 Inhibitor Workflows for Apoptosis Assays
2026-05-02
MCL-1 inhibitor A-1210477 empowers researchers to dissect mitochondrial apoptosis in MCL-1–dependent cancer models with unmatched specificity. This guide delivers actionable protocols, troubleshooting tips, and critical insights from recent literature to maximize the impact and reliability of A-1210477 in advanced cancer research.
-
GSK343: EZH2 Inhibitor Workflows for Epigenetic Cancer Resea
2026-05-01
GSK343 stands out as a selective, cell-permeable EZH2 inhibitor enabling precision control of H3K27me3 and gene repression in cancer and stem cell models. This guide delivers actionable protocols, troubleshooting strategies, and cross-study insights to maximize the impact of GSK343 in advanced epigenetic research workflows.
-
Pretomanid’s Dual Respiratory Inhibition in Tuberculosis The
2026-05-01
This study demonstrates that pretomanid, a bicyclic nitroimidazole derivative, exerts bactericidal activity against Mycobacterium tuberculosis by simultaneously inhibiting both major terminal oxidases of the bacterial respiratory chain. These findings clarify pretomanid’s mechanism, highlight synergistic combinations with other respiratory inhibitors, and inform rational design of next-generation regimens for drug-resistant tuberculosis.
-
Tetraethylammonium Chloride: Optimizing K+ Channel Blockade
2026-04-30
Tetraethylammonium chloride (TEAC) stands as a gold-standard potassium channel blocker, pivotal for dissecting ion conduction and vascular mechanisms. Explore advanced workflows, troubleshooting, and unique innovations that set APExBIO’s TEAC apart for high-resolution, translational research.
-
CA-074: Selective Cathepsin B Inhibitor for Necroptosis & Ca
2026-04-30
Harnessing the nanomolar potency and high selectivity of CA-074, researchers can dissect cathepsin B's pivotal role in necroptosis, cancer metastasis, and immune modulation. Explore robust protocols, troubleshooting insights, and workflow enhancements that translate mechanistic breakthroughs into reproducible experimental outcomes.